News
DBT announces Indo-Australian Biotechnology Fund call
Call for proposal is open from 14th December, 2018 to 23rd January, 2019
Lilly and Aduro Biotech partner to develop novel immunotherapies
As part of the agreement, Lilly will gain access to novel molecules from Aduro that are designed to inhibit the cGAS-STING pathway.
Kineta enters research collaboration and license agreement with Pfizer
The companies will collaborate to develop and test small molecule agonists that target RIG-I, an innate immunostimulatory pathway that can elicit immunogenic cell death (ICD) in tumors.
Bristol-Myers Squibb and Boston Medical Center collaborate to investigate markers of immuno-oncology response and resistance
The comprehensive, multi-dimensional study will place an emphasis on uncovering mechanisms associated with lack of response to Immuno-Oncology (I-O) therapies
Two ABLE BEST winners bag 2018 National Bioentrepreneurship Award
ABLE-BEST winners--KBCols Sciences and Module Innovations--win the second edition of National Bio Entrepreneurship Competition.
Archives
